Sanjivani Paranteral Stock Screener | Share Price & Fundamental Analysis
SANJIVIN
Pharmaceuticals
Screen Sanjivani Paranteral share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹212.40
▼
-12.25 (-5.45%)
Market Cap
₹270.24 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
6.01
EPS (TTM)
₹6.81
Dividend Yield
0.22%
Debt to Equity
0.10
52W High
₹356.70
52W Low
₹181.85
Operating Margin
15.00%
Profit Margin
12.50%
Revenue (TTM)
₹16.00
EBITDA
₹2.00
Net Income
₹2.00
Total Assets
₹78.00
Total Equity
₹40.00
Sanjivani Paranteral Share Price History - Stock Screener Chart
Screen SANJIVIN historical share price movements with interactive charts. Analyze price trends and patterns.
Sanjivani Paranteral Company Profile - Fundamental Screener
Screen Sanjivani Paranteral company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SANJIVIN shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE860D01013
Sanjivani Paranteral Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen SANJIVIN balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 |
|---|---|---|
| Assets | ||
| Total Assets | 78 | 43 |
| Current Assets | 34 | 29 |
| Fixed Assets | 21 | 10 |
| Liabilities | ||
| Total Liabilities | 78 | 43 |
| Current Liabilities | 7 | 2 |
| Non-Current Liabilities | 0 | 0 |
| Shareholders' Equity | ||
| Total Equity | 40 | 28 |
| Share Capital | 12 | 12 |
| Reserves & Surplus | 25 | 14 |
Screen SANJIVIN income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec |
|---|---|---|---|---|---|---|---|---|
| Revenue | 16 | 18 | 19 | 18 | 19 | 17 | 13 | 15 |
| Expenses | 13 | 15 | 16 | 15 | 15 | 14 | 11 | 13 |
| EBITDA | 2 | 3 | 3 | 3 | 3 | 2 | 2 | 2 |
| Operating Profit % | 15.00% | 15.00% | 14.00% | 15.00% | 16.00% | 14.00% | 17.00% | 13.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 2 | 2 | 3 | 3 | 3 | 2 | 2 | 2 |
| Tax | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| Net Profit | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 |
| EPS | 1.33 | 1.46 | 1.84 | 1.62 | 1.96 | 1.47 | 1.08 | 1.65 |
Sanjivani Paranteral Cash Flow Screener - Liquidity Fundamentals
Screen SANJIVIN cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March |
|---|---|---|
| Operating Activities | 12 | -11 |
| Investing Activities | -22 | -12 |
| Financing Activities | 11 | 23 |
| Net Cash Flow | 1 | 0 |
Screen SANJIVIN shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Feb | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 28.87% | 28.87% | 31.20% | 27.67% | 27.67% | 27.67% | 27.67% | 27.67% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 6.15% | 6.15% | 6.03% | 0.00% | 9.70% | 9.36% | 6.25% | 6.25% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 52.43% | 52.60% | 50.99% | 48.46% | 49.98% | 50.67% | 53.90% | 54.08% |
| Other Holding | 12.54% | 12.38% | 11.78% | 23.87% | 12.65% | 12.31% | 12.18% | 11.99% |
| Shareholder Count | 6,447 | 6,429 | 6,307 | 4,800 | 4,911 | 6,166 | 6,731 | 6,618 |
Sanjivani Paranteral Dividend Screener - Share Yield Analysis
Screen SANJIVIN dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Sanjivani Paranteral Index Membership - Market Screener Classification
Screen SANJIVIN by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Sanjivani Paranteral Market Events Screener - Corporate Actions
Screen SANJIVIN market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 23.26% | ||
| Annual General Meeting | NA | 10.60% | ||
| Dividend | ₹ 0.50 /share | 12.66% | ||
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -3.28% |
| 2025-08-12 | 2025-08-12 | Quarterly Result Announcement | NA | 1.05% |
| 2025-05-27 | 2025-05-27 | Quarterly Result Announcement | NA | -1.67% |
| 2025-02-10 | 2025-02-10 | Quarterly Result Announcement | NA | -4.99% |
| 2024-10-28 | 2024-10-28 | Quarterly Result Announcement | NA | -5.46% |
| 2024-01-18 | 2024-01-18 | Extraordinary General Meeting | NA | 0.36% |
Sanjivani Paranteral Competitors Screener - Peer Comparison
Screen SANJIVIN competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 421,299 | 40.53 | 54,729 | 9.71% | 10,980 | 46.18 |
| Divis Laboratories | 171,931 | 69.57 | 9,712 | 18.67% | 2,191 | 53.62 |
| Torrent Pharmaceuticals | 129,290 | 60.33 | 11,539 | 6.99% | 1,911 | 62.04 |
| Cipla | 121,220 | 22.48 | 28,410 | 7.12% | 5,291 | 44.91 |
| Dr Reddys Laboratories | 107,123 | 18.68 | 33,741 | 16.73% | 5,725 | 60.09 |
| Lupin | 96,535 | 22.34 | 22,910 | 13.74% | 3,306 | 60.88 |
| Zydus Life Science | 93,358 | 18.37 | 23,511 | 18.55% | 4,615 | 47.29 |
| Mankind Pharma | 92,029 | 50.91 | 12,744 | 20.90% | 2,007 | 53.62 |
| Aurobindo Pharma | 70,742 | 20.79 | 32,346 | 9.43% | 3,484 | 57.50 |
| Alkem Laboratories | 66,921 | 27.88 | 13,458 | 3.70% | 2,216 | 47.48 |
Sanjivani Paranteral Company Announcements - News Screener
Screen SANJIVIN latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-12-05 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-12-05 | Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot | View |
| 2025-12-05 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | View |
| 2025-11-21 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | View |
| 2025-11-19 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2025-11-18 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-11-15 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-11-15 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-14 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-14 | Regulation 32 For The Quarter Ended 30Th September 2025 | View |
| 2025-11-14 | Financial Results For The Quarter And Half Year Ended 30Th September 2025 | View |
| 2025-11-14 | Board Meeting Outcome for Outcome Of The Second Quarter And Half Year Ended Financial Results Ended 31Th September 2025 | View |
| 2025-11-07 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-07 | Board Meeting Intimation for Intimation Of Notice Of Board Meeting To Be Held On Friday 14Th November 2025 Pursuant To Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |
| 2025-11-04 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | View |
| 2025-10-15 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-08 | Announcement under Regulation 30 (LODR)-Dividend Updates | View |
| 2025-09-29 | Closure of Trading Window | View |
| 2025-09-27 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-09-27 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |